binding affinity News and Research

RSS
The impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant

The impact of epistatic interactions on the ACE2 affinity in the SARS-CoV-2 Omicron variant

21 Jun 2022
Study explains the structural basis of higher ACE2 binding affinity of Omicron sub-variants

Study explains the structural basis of higher ACE2 binding affinity of Omicron sub-variants

17 Jun 2022
Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

Insights on the T cell epitope landscape for the five main SARS-CoV-2 variants of concern

9 Jun 2022
Omicron lineage spike proteins use ACE2 receptors more efficiently

Omicron lineage spike proteins use ACE2 receptors more efficiently

7 Jun 2022
New fluorogenic probe could quickly detect the presence of influenza A virus

New fluorogenic probe could quickly detect the presence of influenza A virus

6 Jun 2022
The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

The effects of accessory protein mutations and other non-spike mutations on SARS-CoV-2 pathogenesis

2 Jun 2022
Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

Tracking the emergence of potential drug-resistant mutations in SARS-CoV-2 proteins

1 Jun 2022
The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

The pineapple-derived jacalin-related lectin as a potential anti-SARS-CoV-2 agent

31 May 2022
Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

Researchers identify a human monoclonal antibody that could broadly neutralize several variants of SARS-CoV-2, SARS-CoV, and other coronaviruses

30 May 2022
Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

Exploring virological profiles of recently emerged SARS-CoV-2 Omicron variants

30 May 2022
Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

Continuous evolution of SARS-CoV-2 Omicron variant yielding immune evasive subvariants

30 May 2022
Computational modeling fine tunes RBD-1C aptamer against SARS-CoV-2 S protein

Computational modeling fine tunes RBD-1C aptamer against SARS-CoV-2 S protein

24 May 2022
The impact of SARS-CoV-2 nucleocapsid protein mutations on the performance of rapid antigen tests

The impact of SARS-CoV-2 nucleocapsid protein mutations on the performance of rapid antigen tests

24 May 2022
Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

Tiny shark-derived antibodies broadly neutralize most SARS-CoV-2 variants

23 May 2022
Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

Compound found in Datura shows promise as antiviral agent against SARS-CoV-2

17 May 2022
Researchers develop treatment that suppresses mutational escape of SARS-CoV-2

Researchers develop treatment that suppresses mutational escape of SARS-CoV-2

17 May 2022
Unique antibody responses after third COVID-19 mRNA vaccination

Unique antibody responses after third COVID-19 mRNA vaccination

16 May 2022
Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

Delta- and Omicron BA.1-variant specificity of B cell repertoires established by an initial Wuhan strain infection

12 May 2022
SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

SARS-CoV-2 Omicron escapes immune response due to high ACE2 affinity and low antibody specificity

12 May 2022
Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

Research highlight reports on the observed differences in transmissibility and pathogenicity of Omicron vs. earlier variants of SARS-CoV-2

10 May 2022

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback